Literature DB >> 6253446

Deoxyuridine triphosphate pools after polyoma virus infection.

S Nilsson, P Reichard, L Skoog.   

Abstract

The synthesis of polyoma DNA in virus-infected 3T6 mouse fibroblasts is discontinuous with the intermediate formation of short Okazaki fragments. Hydroxyurea, an inhibitor of the enzyme ribonucleotide reductase, inhibits polyoma DNA synthesis, as measured by incorporation of radioactive thymidine. In the inhibited state, almost all incorporation occurs into short fragments. We investigated to what extent formation of short DNA fragments might be the result of incorporation of deoxyuridine triphosphate (dUTP) into DNA, followed by excision and repair reactions. We devised a sensitive enzymatic method for measuring dUTP in cell extracts which allows the determination of the dUTP pool when this pool amounts to between 0.1 and 2% of the dTTP pool. No dUTP was detected in growing mouse fibroblasts. After infection with polyoma virus cell extracts contained 0.4% dUTP (of dTTP) at the peak of DNA synthesis. Addition of hydroxyurea at this point led to a disappearance of dUTP. We conclude that dUTP incorporation can contribute only minimally to the generation of short fragments during polyoma DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253446

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Both strands of polyoma DNA are replicated discontinuously with ribonucleotide primers in vivo.

Authors:  M Närkhammar-Meuth; J Kowalski; D T Denhardt
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

Review 2.  Physiological concentrations of purines and pyrimidines.

Authors:  T W Traut
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

3.  Aberrant DNA repair and DNA replication due to an inherited enzymatic defect in human DNA ligase I.

Authors:  C Prigent; M S Satoh; G Daly; D E Barnes; T Lindahl
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.